Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations

Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations

US Patent 11149094 · Granted Oct 19, 2021

Estimated economic value: $332,285,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Proteins comprising CD3 antigen binding domains and uses thereof2025
Anti-CD28 x anti-PSMA antibodies2025
Anti-CD28 x anti-PSMA antibodies2025
Bispecific EGFR/c-Met antibodies2025
Materials and methods for multidirectional biotransportation in virotherapeutics2024
Proteins comprising CD3 antigen binding domains and uses thereof2024
Variable heavy chain only libraries, methods of preparation thereof, and uses th2024
Materials and methods of using engineered ligands2024
Proteins comprising HLA-G antigen binding domains and their uses2023
FC engineered anti-TNFR superfamily member antibodies having enhanced agonistic 2022
Fc γ RIII binding fibronectin type III domains, their conjugates and multispeci2021
Rodent bispecific heterodimeric proteins2020